Matches in SemOpenAlex for { <https://semopenalex.org/work/W2416263960> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2416263960 endingPage "93" @default.
- W2416263960 startingPage "189" @default.
- W2416263960 abstract "The synergistic action of hydroxyurea with some other antiretroviral drugs led us to evaluate the effect of therapy with the combination of didanosine and hydroxyurea in HIV-1-infected patients. We aimed to assess the anti-HIV activity of therapy with this combination by measuring variations in viral load and in CD4 cell counts. We also evaluated the potential side effects of this drug combination in HIV-1-positive patients with advanced disease. A total of 15 HIV-1-seropositive homosexual men with a mean baseline CD4 cell count of 149 cells/mm3 (range: 1-430 cells/mm3) were recruited to the study, and received didanosine (200 mg) plus hydroxyurea (500 mg) twice daily for 12 weeks. Ten patients were didanosine naive and five had previously received didanosine (for > 3 months). The combination therapy was well tolerated, although grade 2-3 alopecia appeared in four patients who had very low CD4 cell counts (< 50 cells/mm3). No significant variation in renal, hepatic and pancreatic functions occurred. A significant reduction in the plasma HIV-1 RNA (> 0.5 logs) was observed in seven of ten patients naive to didanosine after weeks 4 and 12 of the study; five of these patients had a decrease in plasma HIV-1 RNA of > 1.5 logs, with two having a decrease of > 2.0 logs. The viral load became undetectable (below 200 copies/ml) in three patients. The patients whose plasma HIV-1 RNA levels were not significantly reduced by the combination therapy had a higher baseline viral load. CD4 cell counts did not increase significantly in most patients. We observed a better response in those patients who had virus of the non-syncytium-inducing phenotype. In conclusion, hydroxyurea in combination with didanosine was well tolerated and led to a reduction in viral load mainly in patients who were initially naive to didanosine." @default.
- W2416263960 created "2016-06-24" @default.
- W2416263960 creator A5013211252 @default.
- W2416263960 creator A5014663441 @default.
- W2416263960 creator A5028130303 @default.
- W2416263960 creator A5036044360 @default.
- W2416263960 creator A5040278584 @default.
- W2416263960 creator A5054027483 @default.
- W2416263960 creator A5057039777 @default.
- W2416263960 creator A5063732313 @default.
- W2416263960 date "1996-08-01" @default.
- W2416263960 modified "2023-09-26" @default.
- W2416263960 title "Short-term anti-HIV activity of the combination of didanosine and hydroxyurea." @default.
- W2416263960 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11322253" @default.
- W2416263960 hasPublicationYear "1996" @default.
- W2416263960 type Work @default.
- W2416263960 sameAs 2416263960 @default.
- W2416263960 citedByCount "7" @default.
- W2416263960 crossrefType "journal-article" @default.
- W2416263960 hasAuthorship W2416263960A5013211252 @default.
- W2416263960 hasAuthorship W2416263960A5014663441 @default.
- W2416263960 hasAuthorship W2416263960A5028130303 @default.
- W2416263960 hasAuthorship W2416263960A5036044360 @default.
- W2416263960 hasAuthorship W2416263960A5040278584 @default.
- W2416263960 hasAuthorship W2416263960A5054027483 @default.
- W2416263960 hasAuthorship W2416263960A5057039777 @default.
- W2416263960 hasAuthorship W2416263960A5063732313 @default.
- W2416263960 hasConcept C126322002 @default.
- W2416263960 hasConcept C142462285 @default.
- W2416263960 hasConcept C203014093 @default.
- W2416263960 hasConcept C2776694085 @default.
- W2416263960 hasConcept C2776999253 @default.
- W2416263960 hasConcept C2777447569 @default.
- W2416263960 hasConcept C2779316324 @default.
- W2416263960 hasConcept C2993143319 @default.
- W2416263960 hasConcept C3013748606 @default.
- W2416263960 hasConcept C71924100 @default.
- W2416263960 hasConcept C90924648 @default.
- W2416263960 hasConcept C98274493 @default.
- W2416263960 hasConceptScore W2416263960C126322002 @default.
- W2416263960 hasConceptScore W2416263960C142462285 @default.
- W2416263960 hasConceptScore W2416263960C203014093 @default.
- W2416263960 hasConceptScore W2416263960C2776694085 @default.
- W2416263960 hasConceptScore W2416263960C2776999253 @default.
- W2416263960 hasConceptScore W2416263960C2777447569 @default.
- W2416263960 hasConceptScore W2416263960C2779316324 @default.
- W2416263960 hasConceptScore W2416263960C2993143319 @default.
- W2416263960 hasConceptScore W2416263960C3013748606 @default.
- W2416263960 hasConceptScore W2416263960C71924100 @default.
- W2416263960 hasConceptScore W2416263960C90924648 @default.
- W2416263960 hasConceptScore W2416263960C98274493 @default.
- W2416263960 hasIssue "3" @default.
- W2416263960 hasLocation W24162639601 @default.
- W2416263960 hasOpenAccess W2416263960 @default.
- W2416263960 hasPrimaryLocation W24162639601 @default.
- W2416263960 hasRelatedWork W2031410120 @default.
- W2416263960 hasRelatedWork W2040582663 @default.
- W2416263960 hasRelatedWork W2082114427 @default.
- W2416263960 hasRelatedWork W2117940098 @default.
- W2416263960 hasRelatedWork W2125425121 @default.
- W2416263960 hasRelatedWork W2130305699 @default.
- W2416263960 hasRelatedWork W2409173907 @default.
- W2416263960 hasRelatedWork W2410182663 @default.
- W2416263960 hasRelatedWork W2416263960 @default.
- W2416263960 hasRelatedWork W2412769044 @default.
- W2416263960 hasVolume "1" @default.
- W2416263960 isParatext "false" @default.
- W2416263960 isRetracted "false" @default.
- W2416263960 magId "2416263960" @default.
- W2416263960 workType "article" @default.